Matches in SemOpenAlex for { <https://semopenalex.org/work/W1750961675> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1750961675 endingPage "1302" @default.
- W1750961675 startingPage "1299" @default.
- W1750961675 abstract "Despite anti-haemorrhagic therapy with proper doses of activated prothrombin complex concentrate (aPCC, Feiba®), patients with acquired haemophilia A (AHA) have a considerable risk of recurrent bleeding complications. Evidence in support of the benefit-to-risk ratio of prevention strategies with the use of lower doses of aPCC following the end of the initial treatment period is scarce and inconclusive. We report our experience in the management of 18 consecutive patients with AHA admitted to two Haemophilia centres in Italy. We managed the first 11 according to current guidelines (e.g., with conventional aPCC doses until bleeding resolution). Then, we decided to prolong the treatment beyond bleeding resolution with lower doses of the same concentrate (short-term prophylaxis) in the 7 additional patients. In these patients, the treatment was continued for as long as the titre of FVIII inhibitor was found to decrease by at least 50% when compared to the baseline one. We observed six relapses of bleeding in patients in whom aPCC was confined to the treatment of the qualifying bleeding episode, and none in patients to whom lower doses were administered until the pre-specified decrease in the titre of FVIII inhibitor was achieved. No patients experienced thrombotic complications during the study period. Prolonging the treatment with lower doses of aPCC beyond the initial phase in patients with AHA in whom the titre of FVIII inhibitor is still high is likely to safely prevent further bleeding complications." @default.
- W1750961675 created "2016-06-24" @default.
- W1750961675 creator A5000966916 @default.
- W1750961675 creator A5002412476 @default.
- W1750961675 creator A5005727824 @default.
- W1750961675 creator A5032961667 @default.
- W1750961675 creator A5040991094 @default.
- W1750961675 creator A5048625976 @default.
- W1750961675 creator A5059116622 @default.
- W1750961675 creator A5071745188 @default.
- W1750961675 date "2015-12-01" @default.
- W1750961675 modified "2023-10-13" @default.
- W1750961675 title "Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study" @default.
- W1750961675 cites W1497770400 @default.
- W1750961675 cites W1792313494 @default.
- W1750961675 cites W1966116086 @default.
- W1750961675 cites W1967479627 @default.
- W1750961675 cites W1973565540 @default.
- W1750961675 cites W1998079268 @default.
- W1750961675 cites W2001205289 @default.
- W1750961675 cites W2013127651 @default.
- W1750961675 cites W2039064237 @default.
- W1750961675 cites W2047967564 @default.
- W1750961675 cites W2060795722 @default.
- W1750961675 cites W2061024262 @default.
- W1750961675 cites W2087845370 @default.
- W1750961675 cites W2108177522 @default.
- W1750961675 cites W2140779455 @default.
- W1750961675 cites W2147073169 @default.
- W1750961675 cites W2157045826 @default.
- W1750961675 cites W2162535497 @default.
- W1750961675 cites W2167864435 @default.
- W1750961675 cites W2989714602 @default.
- W1750961675 doi "https://doi.org/10.1016/j.thromres.2015.10.032" @default.
- W1750961675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26505666" @default.
- W1750961675 hasPublicationYear "2015" @default.
- W1750961675 type Work @default.
- W1750961675 sameAs 1750961675 @default.
- W1750961675 citedByCount "17" @default.
- W1750961675 countsByYear W17509616752017 @default.
- W1750961675 countsByYear W17509616752018 @default.
- W1750961675 countsByYear W17509616752019 @default.
- W1750961675 countsByYear W17509616752020 @default.
- W1750961675 countsByYear W17509616752022 @default.
- W1750961675 countsByYear W17509616752023 @default.
- W1750961675 crossrefType "journal-article" @default.
- W1750961675 hasAuthorship W1750961675A5000966916 @default.
- W1750961675 hasAuthorship W1750961675A5002412476 @default.
- W1750961675 hasAuthorship W1750961675A5005727824 @default.
- W1750961675 hasAuthorship W1750961675A5032961667 @default.
- W1750961675 hasAuthorship W1750961675A5040991094 @default.
- W1750961675 hasAuthorship W1750961675A5048625976 @default.
- W1750961675 hasAuthorship W1750961675A5059116622 @default.
- W1750961675 hasAuthorship W1750961675A5071745188 @default.
- W1750961675 hasConcept C141071460 @default.
- W1750961675 hasConcept C2777232031 @default.
- W1750961675 hasConcept C2778385053 @default.
- W1750961675 hasConcept C71924100 @default.
- W1750961675 hasConceptScore W1750961675C141071460 @default.
- W1750961675 hasConceptScore W1750961675C2777232031 @default.
- W1750961675 hasConceptScore W1750961675C2778385053 @default.
- W1750961675 hasConceptScore W1750961675C71924100 @default.
- W1750961675 hasIssue "6" @default.
- W1750961675 hasLocation W17509616751 @default.
- W1750961675 hasLocation W17509616752 @default.
- W1750961675 hasOpenAccess W1750961675 @default.
- W1750961675 hasPrimaryLocation W17509616751 @default.
- W1750961675 hasRelatedWork W1995822104 @default.
- W1750961675 hasRelatedWork W2005719195 @default.
- W1750961675 hasRelatedWork W2067082011 @default.
- W1750961675 hasRelatedWork W2086676349 @default.
- W1750961675 hasRelatedWork W2101928171 @default.
- W1750961675 hasRelatedWork W2166990743 @default.
- W1750961675 hasRelatedWork W3113163854 @default.
- W1750961675 hasRelatedWork W3155450815 @default.
- W1750961675 hasRelatedWork W4233505807 @default.
- W1750961675 hasRelatedWork W4292525692 @default.
- W1750961675 hasVolume "136" @default.
- W1750961675 isParatext "false" @default.
- W1750961675 isRetracted "false" @default.
- W1750961675 magId "1750961675" @default.
- W1750961675 workType "article" @default.